Brief: CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23
30/07/2026 21:02
BRIEF-CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23 Jul 30 (Reuters) - CareDx Q2 net income USD 111 million.
- Q2 adjusted net income USD 20 million
- Q2 revenue USD 132 million vs. IBES estimate USD 114 million
- Q2 adjusted EBITDA USD 25 million
Recent news on CareDx
See all newsBrief: Caredx Announces New Koar Data Linking Elevated Allosure® Kidney To Nearly 3-Fold Higher Risk Of Adverse Graft Outcomes In Patients With Borderline Rejection Or Tcmr At Asn Kidney Week 2026
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
CareDx Inc reports results for the quarter ended June 30 - Earnings Summary
CareDx Q2 revenue beats estimates; outlook lifted
Brief: CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23